Close Menu


Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigator Unit Sponsor Date
Overcoming Immune Barriers to Stem Cell-Derived Beta Cell Transplantation Grant $199,999.98 Research Deepta Bhattacharya Immunobiology The New York Stem Cell Foundation 05/2020
Novel Gene Based Therapy for Nemaline Myopathy Grant $88,792.00 Research Hendrikus Granzier Cellular & Molecular Medicine Hospital for Sick Children (Canada) 05/2020
NRG Oncology NCORP Research Base Cooperative Agreement $144,704.00 Research Cynthia Thomson Cancer Center Division NRG Oncology 05/2020
Meaningful Drug-Drug Interactions Alerts Grant $21,071.00 Research Sheila Gephart College of Nursing University of Utah 05/2020
Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Severe Influenza Associated Illness in US Children Contract $44,500.00 Research Mary Gaspers Pediatrics Boston Children's Hospital 05/2020
Hemolysis and Free Heme Signaling in Pulmonary Hypertension Grant $2,071,020.00 Research Ruslan Rafikov Medicine National Heart, Lung, and Blood Institute 05/2020
Epigenetic Evaluation of WUI Firefighters Contract $380,478.00 Research Jefferey Burgess Community Environment & Policy Bureau Veritas North America 05/2020
Enhanced Mitochondrial Function to Increase Effectiveness of Post-Stroke Rehabilitation (IPA for Helena Morrison) Contract $37,164.14 Research Rick Schnellmann Pharmacy Administration United States Department of Veterans Affairs 05/2020
Endometriosis, Infertility, and Risk of Stroke Grant $442,205.00 Research Leslie Farland Epidemiology and Biostatistics Eunice Kennedy Shriver National Institute of Child Health and Human Development 05/2020
Development of Amygdalo-Prefrontal Connections in Adolescent Macaques Grant $1,151,246.00 Research Katalin Gothard Physiology National Institute of Mental Health 05/2020
Arrest Respiratory Failure Due to Pneumonia (ARREST PNEUMONIA) Cooperative Agreement $458,244.00 Research Christian Bime Medicine Stanford University 05/2020
Applied Research to Address the Coronavirus (COVID-19) Emerging Public Health Emergency Contract $10,000.00 Research Jefferey Burgess Community Environment & Policy Abt Associates 05/2020
Coronavirus State Hospital Improvement Program Grant $1,349,072.00 Other Sponsored Activity Leila Barraza Community Environment & Policy Health Resources and Services Administration 05/2020
Training Long Term - Pediatric Pulmonary Centers Grant $1,700,000.00 Instruction Cori Daines Pediatrics Health Resources and Services Administration 05/2020
Phase 1 Study of VE800 and Nivolumab in Patients with Selected Types of Advanced or Metastatic Cancer Contract $323,394.75 Clinical Trial Hani Babiker Cancer Center Division Vedanta Biosciences, Inc. 05/2020
Disease Morphology Image Study Protocol: A Retrospective, Multicenter, Data collection study for information about the disease morphology and stent restenosis patterns in the Iliac and SFA arteries, w Contract $17,187.52 Clinical Trial Kresimira Milas Surgery Bard Peripheral Vascular, Inc. 05/2020
A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately Contract $395,132.40 Clinical Trial Sasha Taleban Medicine PPD Investigator Services, LLC. 05/2020
A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma (TRYbeCA-1 - TRial of ErYaspase Contract $664,687.53 Clinical Trial Hani Babiker Cancer Center Division PPD Investigator Services, LLC. 05/2020
A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic... Contract $297,912.00 Clinical Trial Rachna Shroff Cancer Center Division Covance, Incorporated 05/2020
A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial To Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Infants Born to.... Contract $124,499.00 Clinical Trial Mohamed Ahmed Pediatrics Pfizer, Incorporated 05/2020
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of VX-814 in PiZZ Subjects Contract $79,672.00 Clinical Trial Ramachandra Sista COM Phx Internal Medicine Vertex Pharmaceuticals, Incorporated 05/2020
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants with Previously Treated Locally Advanced/Metastatic or Surgically Unresectable.. Contract $171,440.00 Clinical Trial Aaron Scott Cancer Center Division Incyte Corporation 05/2020
A Phase 2 Open-Label Study of Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-cell Lymphoma (PTCL) in Adults Age 60 and Above Contract $147,691.00 Clinical Trial Daniel Persky Cancer Center Division Seattle Genetics, Incorporated 05/2020
Total Worker Health for Wildland Firefighters Grant $74,540.00 Research Jefferey Burgess Community Environment & Policy Oregon Health and Science University 04/2020
Contract $231,030.00 Clinical Trial Steve Chung COM Phx Neurology NCGS Incorporated 03/2020